Edition:
United Kingdom

People: Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,613.15INR
11:21am BST
Change (% chg)

Rs-42.40 (-1.60%)
Prev Close
Rs2,655.55
Open
Rs2,659.95
Day's High
Rs2,680.00
Day's Low
Rs2,604.05
Volume
468,248
Avg. Vol
679,351
52-wk High
Rs2,964.00
52-wk Low
Rs1,872.95

Prasad, G. 

Mr. G. V. Prasad serves as a Co-Chairman of the Board, Chief Executive Officer, Managing Director of the Company. Mr. G V Prasad leads the core team at Dr. Reddy’s that has contributed signifi cantly to its transformation from a mid-sized domestic operation into a global pharmaceutical major. He is the architect of Dr. Reddy’s successful Global Generics and Active Pharmaceutical Ingredient (API) strategies, as well as the company’s foray into biosimilars and diff erentiated formulations. Mr. Prasad is engaged with strengthening the company’s research and development capabilities, supporting progressive people practices and building a holistic culture of operational excellence. He was listed in the prestigious ‘Medicine Maker 2018 Power List’ of most inspirational professionals shaping the future of drug development, and one of ‘India’s Greatest 50 CEOs Ever’ by Outlookmagazine in 2017. Mr. Prasad holds a degree in Chemical Engineering from the Illinois Institute of Technology, Chicago, USA and a Masters in Industrial Administration from Purdue University, USA.q

Basic Compensation

Total Annual Compensation, INR 93,515,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 93,515,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

69,315,000

G. Prasad

93,515,000

Saumen Chakraborty

39,930,000

MARC KIKUCHI

--

M. Ramana

--

Erez Israeli

--
As Of  31 Mar 2019